Indicators for monitoring the 2016 United Nations Political Declaration on Ending AIDS
UNAIDS supports countries to collect information on their national HIV responses through the Global AIDS Monitoring (GAM) framework—an annual collection of 72 indicators on the response to HIV in a country.... These data form part of the data set used to report back to the General Assembly.
Different from the HIV epidemiological estimates that countries produce for data on the state of the epidemic in a country—that is, data for making estimates on the number of people living with HIV, AIDS-related deaths, etc.—GAM collects information on HIV programmes, including the number of people living with HIV who know their HIV status and people on HIV treatment, and on stigma and discrimination. A full list of the indicators is given in the GAM guidelines.
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                UNAIDS 2018, Guidance 
Indicators for monitoring the
2016 Political Declaration on Ending AIDS
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                The purpose of the WHO Manual for the Public Health Management of Chemical Incidents is to provide a comprehensive overview of the principles and roles of public health in the management of chemical incidents and emergencies. While this information is provided for each phase of the emergency cycle, ...including prevention, planning and preparedness, detection and alert, response and recovery, it is recognized that the management of chemical incidents and emergencies requires a multi-disciplinary and multi-sectoral approach and that the health sector may play an influencing, complementary or a leadership role at various stages of the management process. The target audience includes public health and environmental professionals, as well as any other person involved in the management of chemical incidents.
WHO and all those involved in the development of the publication hope that the publication will have wide application, especially in developing countries and countries with economies in transition, and that in the future the health sector will be better prepared to acknowledge and fulfill its roles and responsibilities in the management of chemical incidents and emergencies, thereby contributing to the prevention and mitigation of their health consequences.
The publication is also available in French: http://apps.who.int/iris/bitstream/handle/10665/246117/9789242598148-fre.pdf?sequence=1 and in Spanish: http://apps.who.int/iris/bitstream/handle/10665/246118/9789243598147-spa.pdf?sequence=1
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Ce profil pays est le résultat d'une évaluation du paysage menée par le personnel et les collègues d'Advancing Partners & Communuties (APC). Cette évaluation du paysage portait sur les pays prioritaires de l'Agence des États-Unis pour le Développement International (USAID) en termes de Popula...tion et de Santé de la Reproduction, et s'intéressait plus particulièrement à la planification familiale car c'est le point central du projet APC. Le but de l'évaluation du paysage fut de recueillir les informations les plus récentes disponibles sur le système de santé communautaire, les agents de santé communautaires et les services de santé communautaires dans chaque pays. Ce profil est destiné à refléter les informations recueillies. Lorsque cela est possible, les informations présentées sont justifiées par les politiques nationales et d'autres documents pertinents ; cependant, une grande partie des informations sont le résultat de l'expertise institutionnelle et d'entrevues personnelles en raison de l'absence relative d'informations publiquement disponibles sur les systèmes nationaux de santé communautaires. En conséquence, des lacunes et des incohérences peuvent exister dans ce profil. 
                                                                    more
                                                            
                         
                     
                                                        
                        
                        
                            
                            
                                                                Malaria in pregnancy is a significant health problem in malaria-endemic areas. It not only causes substantial childhood morbidity and mortality but also increases the risks of adverse events for pregnant women and their developing fetuses. Most of the burden in these areas is due to infection with P...lasmodium falciparum. Artemisinin-based combination therapy (ACT) has been recommended as first-line treatment for uncomplicated P. falciparum malaria in all populations, including pregnant women in their second and third trimesters, since 2006. However, for women in their first trimester of pregnancy, WHO recommended as first-line treatment a combination of quinine and clindamycin.
Based on a review of the evidence conducted in 2022, WHO now recommends artemether–lumefantrine, the ACT with the most human safety data available, as the preferred treatment for uncomplicated P. falciparum malaria in the first trimester of pregnancy. This document presents all relevant evidence on the effects and safety in early pregnancy of artemisinins and partner medicines used in ACTs from both studies in experimental animals and observational studies in humans.
                                                                    more